Advanced glycation end products (AGEs) are potentially harmful and heterogeneous
molecules derived from nonenzymatic glycation. The pathological implications of AGEs are …

Obesity and diabetes are leading causes of cardiovascular morbidity and mortality. Although
extensive strides have been made in the treatments for non-diabetic atherosclerosis and its …

Lines of evidence from several studies have shown that increases in life expectancy are now
accompanied by increased disability rate. The expanded lifespan of the aging population …

The rapid increase in metabolic diseases, which occurred in the last three decades in both
industrialized and developing countries, has been related to the rise in sugar-added foods …

The role of advanced glycation end products (AGEs) in promoting and/or exacerbating
metabolic dysregulation is being increasingly recognized. AGEs are formed when reducing …

Cardiovascular disease remains a leading cause of morbidity and mortality in people with
types 1 or 2 diabetes mellitus. Although beneficial roles for strict control of hyperglycemia …

Osteoarthritis (OA) is a heterogeneous disorder with several risk factors. Among them,
obesity has a major impact on both loading and non-loading joints. Mechanical overload …

Polycystic ovary syndrome (PCOS), a multisystem disease, is a major reason for female
infertility around the world. It is no longer considered simply as a disease of ovary. Now …

Advanced glycation end-products (AGEs) are an assorted group of molecules formed
through covalent bonds between a reduced sugar and a free amino group of proteins, lipids …

The macro-and microvascular complications of type 1 and 2 diabetes lead to increased
disease severity and mortality. The receptor for advanced glycation end products (RAGE) …